Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study

Safinamide is a selective, reversible, monoamine oxidase B inhibitor for the treatment of patients with Parkinson's disease (PD) and motor fluctuations. This was a post hoc analysis of the SETTLE study, in which patients with PD and motor fluctuations were randomly assigned to 24-week treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhidayasiri, Roongroj, Koebis, Michinori, Kamei, Takanori, Ishida, Takayuki, Suzuki, Ippei, Cho, Jin Whan, Wu, Shey-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083404/
https://www.ncbi.nlm.nih.gov/pubmed/37051060
http://dx.doi.org/10.3389/fneur.2023.1147008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083404/
https://www.ncbi.nlm.nih.gov/pubmed/37051060
http://dx.doi.org/10.3389/fneur.2023.1147008

Ejemplares similares